Skip to main content
Veterinary Medicines

Nobilis Ma5 + CLONE 30

Authorised
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live

Product identification

Medicine name:
Nobilis Ma5 + CLONE 30
Active substance:
  • Newcastle disease virus, strain Clone 30, Live
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
Target species:
  • Chicken
  • Chicken (chick)
Route of administration:
  • Nebulisation use
  • Oculonasal use

Product details

Active substance and strength:
  • Newcastle disease virus, strain Clone 30, Live
    6.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
  • Avian infectious bronchitis virus, type Massachusetts, strain Ma5, Live
    4.00
    log 10 50% embryo infective dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for oral suspension
Withdrawal period by route of administration:
  • Nebulisation use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
    • Chicken (chick)
      • Meat and offal
        0
        day
      • Egg
        0
        day
  • Oculonasal use
    • Chicken
      • Egg
        0
        day
      • Meat and offal
        0
        day
    • Chicken (chick)
      • Meat and offal
        0
        day
      • Egg
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD11
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 190a/92
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 5/04/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."